Register for real-time alerts, custom portfolio, and market movers

Get Started

PSTI Pluristem Therapeutics Inc

1.00

0.00 (0.00%)

Pre Market

Last Updated: 20:00:00

Delayed by 15 minutes

Pluristem's Phase II PLX-PAD cells studies in COVID-19 fail to meet primary endpoint

To read the full story on Seeking Alpha, click here.

Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Pluristem Therapeutics Charts.

Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Pluristem Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Pluristem Therapeutics Inc News

More Pluristem Therapeutics Inc News Articles

Branded Legacy (PK)

Net Savings Link (PK)

FBEC Worldwide (PK)

Clean Vision (QB)

Therapeutic Solutions (PK)

Buildablock (PK)

Sunshine Biopharma

Ronn Motor (PK)

Ubiquitech Software (PK)

Enzolytics (PK)

Hannover House (PK)

BlackStar Enterprise (PK)

Delayed Upgrade Clock